ウェアラブルインジェクター市場レポート：2030年までの動向、予測、競合分析

ウェアラブルインジェクターの動向と予測

世界のウェアラブルインジェクター市場は、2024～2030年のCAGR 9.5%で、2030年までに推定146億米ドルに達すると予想されています。この市場の主要促進要因は、患者の利便性への注目の高まりと在宅治療への需要の高まりです。世界のウェアラブルインジェクター市場の将来は、病院やクリニック、在宅医療環境市場での機会があり、有望に見えます。

ウェアラブルインジェクター市場別洞察

Lucintelは、これらのパッチは自宅で簡単に使用でき、耐水性があり、皮膚（胃）に快適に着用できるため、ボディ用インジェクターの人気が高まっているため、予測期間中にさらに高い成長が見込まれると予測しています。

この市場の中で、在宅医療環境は、投薬の自己管理に対する需要の高まりと医療費削減への要望により、予測期間中にさらに高い成長を遂げると予想されます。

北米は、慢性疾患と生活習慣病の症例数の増加、堅牢な医療インフラの利用可能性、この地域における主要企業の存在により、予測期間中に最も高い成長を遂げると予想されています。

よくある質問

Q1.市場規模は：

A1.世界のウェアラブルインジェクター市場は、2030年までに推定146億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.世界のウェアラブルインジェクター市場は、2024～2030年にかけて9.5%のCAGRで成長すると予想されています。

Q3.市場の成長に影響を与える主要促進要因は：

A3.この市場の主要促進要因は、患者の利便性への注目の高まりと在宅治療への需要の高まりです。

Q4.市場の主要セグメントは：

A4.ウェアラブルインジェクター市場の将来は、病院やクリニック、在宅医療環境市場での機会があり、有望に見えます。

Q5.市場の主要企業は：

A5.主要なウェアラブルインジェクター企業の一部は次のとおりです。

• Ypsomed
• Amgen
• Subcuject
• Enable Injections
• Medtronic

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、これらのパッチは自宅で簡単に使用でき、耐水性があり、皮膚（胃）に快適に着用できるため、ボディ用インジェクターの人気が高まっているため、予測期間中にさらに高い成長が見込まれると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は、慢性疾患と生活習慣病の症例数の増加、堅牢な医療インフラの利用可能性、この地域における主要企業の存在により、予測期間中に最も高い成長を遂げると予想されています。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを記載しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のウェアラブルインジェクター市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018～2030年の市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のウェアラブルインジェクター市場動向（2018～2023年）と予測（2024～2030年）
• タイプ別の世界のウェアラブルインジェクター市場
  • オンボディインジェクター
  • オフボディインジェクター
• 技術別の世界のウェアラブルインジェクター市場
  • スプリングベース
  • モーターベース
  • ロータリーポンプ
  • 拡張バッテリー
  • その他
• 治療法別の世界のウェアラブルインジェクター市場
  • 腫瘍免疫学
  • 糖尿病
  • 循環器疾患
  • その他
• 最終用途別の世界のウェアラブルインジェクター市場
  • 病院とクリニック
  • 在宅医療

第4章 2018～2030年の地域別の市場動向と予測分析

• 地域別の世界のウェアラブルインジェクター市場
• 北米のウェアラブルインジェクター市場
• 欧州のウェアラブルインジェクター市場
• アジア太平洋のウェアラブルインジェクター市場
• その他地域のウェアラブルインジェクター市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • タイプ別の世界のウェアラブルインジェクター市場の成長機会
  • 技術別の世界のウェアラブルインジェクター市場の成長機会
  • 治療別の世界のウェアラブルインジェクター市場の成長機会
  • 最終用途別の世界のウェアラブルインジェクター市場の成長機会
  • 地域別の世界のウェアラブルインジェクター市場の成長機会
• 世界のウェアラブルインジェクター市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のウェアラブルインジェクター市場の能力拡大
  • 世界のウェアラブルインジェクター市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Ypsomed
• Amgen
• Subcuject
• Enable Injections
• Medtronic

Wearable Injector Trends and Forecast

The future of the global wearable injector market looks promising with opportunities in the hospital & clinic and home healthcare setting markets. The global wearable injector market is expected to reach an estimated $14.6 billion by 2030 with a CAGR of 9.5% from 2024 to 2030. The major drivers for this market are growing focus on patient convenience and rising demand for home-based treatment.

A more than 150-page report is developed to help in your business decisions.

Wearable Injector by Segment

The study includes a forecast for the global wearable injector by type, technology, therapy, end use, and region.

Wearable Injector Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• On-Body Injector
• Off-Body Injector

Wearable Injector Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Spring Based
• Motor Based
• Rotary Pump
• Expanding Battery
• Others

Wearable Injector Market by Therapy [Shipment Analysis by Value from 2018 to 2030]:

• Immuno-Oncology
• Diabetes
• Cardiovascular Disease
• Others

Wearable Injector Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Clinics
• Home Healthcare Setting

Wearable Injector Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Wearable Injector Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies wearable injector companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the wearable injector companies profiled in this report include-

• Ypsomed
• Amgen
• Subcuject
• Enable Injections
• Medtronic

Wearable Injector Market Insights

Lucintel forecasts that on body injector is expected to witness the higher growth over the forecast period due to its growing popularity as these patches are easy to use at home, water resistant, and comfortable to wear on the skin (stomach).

Within this market, home healthcare setting is expected to witness the higher growth over the forecast period due to growing demand for self-administration of medication and desire to reduce healthcare expenses.

North America is expected to witness highest growth over the forecast period due to growing cases of of chronic & lifestyle-related diseases, availability of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global Wearable Injector Market

Market Size Estimates: Wearable injector market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Wearable injector market size by various segments, such as by type, technology, therapy, end use, and region in terms of value ($B).

Regional Analysis: Wearable injector market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, therapies, end uses, and regions for the wearable injector market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the wearable injector market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the wearable injector market size?

Answer: The global wearable injector market is expected to reach an estimated $14.6 billion by 2030.

Q2. What is the growth forecast for wearable injector market?

Answer: The global wearable injector market is expected to grow with a CAGR of 9.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the wearable injector market?

Answer: The major drivers for this market are growing focus on patient convenience and rising demand for home-based treatment.

Q4. What are the major segments for wearable injector market?

Answer: The future of the wearable injector market looks promising with opportunities in the hospital & clinic and home healthcare setting markets.

Q5. Who are the key wearable injector market companies?

Answer: Some of the key wearable injector companies are as follows:

• Ypsomed
• Amgen
• Subcuject
• Enable Injections
• Medtronic

Q6. Which wearable injector market segment will be the largest in future?

Answer: Lucintel forecasts that on body injector is expected to witness the higher growth over the forecast period due to its growing popularity as these patches are easy to use at home, water resistant, and comfortable to wear on the skin (stomach).

Q7. In wearable injector market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing cases of of chronic & lifestyle-related diseases, availability of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the wearable injector market by type (on-body injector and off-body injector), technology (spring based, motor based, rotary pump, expanding battery, and others), therapy (immuno-oncology, diabetes, cardiovascular disease, and others), end use (hospitals and clinics and home healthcare setting), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Wearable Injector Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Wearable Injector Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Wearable Injector Market by Type
  • 3.3.1: On-Body Injector
  • 3.3.2: Off-Body Injector
• 3.4: Global Wearable Injector Market by Technology
  • 3.4.1: Spring Based
  • 3.4.2: Motor Based
  • 3.4.3: Rotary Pump
  • 3.4.4: Expanding Battery
  • 3.4.5: Others
• 3.5: Global Wearable Injector Market by Therapy
  • 3.5.1: Immuno-Oncology
  • 3.5.2: Diabetes
  • 3.5.3: Cardiovascular Disease
  • 3.5.4: Others
• 3.6: Global Wearable Injector Market by End Use
  • 3.6.1: Hospitals and Clinics
  • 3.6.2: Home Healthcare Setting

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Wearable Injector Market by Region
• 4.2: North American Wearable Injector Market
  • 4.2.2: North American Wearable Injector Market by End Use: Hospitals and Clinics and Home Healthcare Setting
• 4.3: European Wearable Injector Market
  • 4.3.1: European Wearable Injector Market by Type: On-Body Injector and Off-Body Injector
  • 4.3.2: European Wearable Injector Market by End Use: Hospitals and Clinics and Home Healthcare Setting
• 4.4: APAC Wearable Injector Market
  • 4.4.1: APAC Wearable Injector Market by Type: On-Body Injector and Off-Body Injector
  • 4.4.2: APAC Wearable Injector Market by End Use: Hospitals and Clinics and Home Healthcare Setting
• 4.5: ROW Wearable Injector Market
  • 4.5.1: ROW Wearable Injector Market by Type: On-Body Injector and Off-Body Injector
  • 4.5.2: ROW Wearable Injector Market by End Use: Hospitals and Clinics and Home Healthcare Setting

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Wearable Injector Market by Type
  • 6.1.2: Growth Opportunities for the Global Wearable Injector Market by Technology
  • 6.1.3: Growth Opportunities for the Global Wearable Injector Market by Therapy
  • 6.1.4: Growth Opportunities for the Global Wearable Injector Market by End Use
  • 6.1.5: Growth Opportunities for the Global Wearable Injector Market by Region
• 6.2: Emerging Trends in the Global Wearable Injector Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Wearable Injector Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Wearable Injector Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ypsomed
• 7.2: Amgen
• 7.3: Subcuject
• 7.4: Enable Injections
• 7.5: Medtronic